Fiji, a Pacific island nation more accustomed to being celebrated for its beaches and honeymoon resorts, is now grappling with a public health emergency that has drawn international attention. In mid-September, the government declared a national emergency in response to an alarming surge in HIV infections, a crisis that health experts say is being driven in large part by a parallel epidemic of crystal methamphetamine use.
The numbers are stark. HIV cases in Fiji have risen twelvefold between 2010 and 2025, according to UNAIDS. Health officials estimate there may be more than 9,000 people living with the virus, and the country's health minister has stated that roughly one in sixty adults is now HIV-positive. That prevalence rate places Fiji in territory far removed from its image as an idyllic tourist destination.
At the AIDS 2026 conference held in Rio de Janeiro in July, Jason Mitchell, a public health specialist who leads Fiji's HIV response, described the situation as the fastest-growing HIV epidemic anywhere in the world. He noted that two-thirds of cases are concentrated among people between the ages of 20 and 34 — the cohort that typically forms the backbone of a nation's workforce and civic life.
"Our young, active, productive population is currently being infected with HIV, and unless we find solutions quickly, this will continue to get worse," Mitchell warned, underscoring the urgency of the moment.
Behind the rising infection numbers lies another, equally troubling trend: the rampant use of crystal meth among Fiji's youth. Many users inject the drug, and the sharing of needles has become a primary route of HIV transmission. The two epidemics, experts say, are now tightly intertwined, each amplifying the harm caused by the other.
The human cost is already visible. Mark Lal, a 25-year-old HIV activist from Suva, Fiji's capital, has lost friends to the intertwined crises. "Two of my best friends passed away," said Lal, who founded the organization Living Positive Fiji and also serves as a reconciliation officer for the Fiji Truth and Reconciliation Commission. "The majority of my friends, they got HIV through crystal meth."
Lal's account reflects a broader pattern in which drug use and infection are no longer separate problems but mutually reinforcing ones, particularly among young adults who may lack access to prevention services or accurate information about safe injection practices.
Crystal meth has been present in Fiji to some degree for years. The archipelago has long functioned as a transit point for the drug as it moves from South America toward destinations such as Australia and New Zealand. But since the COVID-19 pandemic, meth consumption within Fiji itself has increased dramatically — a shift that HIV experts attribute to a combination of rising unemployment and increasingly accessible drug supplies.
The pandemic's economic fallout left many Fijians without stable work, and the resulting hardship created conditions in which drug use could take root and spread. What was once primarily a trafficking corridor has increasingly become a domestic market, with consequences that are now being measured in HIV diagnoses among young people.
The scale of the challenge has prompted Fiji's government to take extraordinary measures. Declaring a national emergency signals that officials view the situation as beyond the capacity of routine public health programming. Such a declaration can unlock emergency funding, streamline the deployment of resources, and focus national attention on a crisis that might otherwise remain underrecognized.
The demographic profile of the epidemic adds to the concern. With two-thirds of infections occurring among people aged 20 to 34, Fiji faces the prospect of a generation whose health, productivity, and longevity are at risk. The loss of young adults to illness would ripple through families, communities, and the national economy for decades.
Public health specialists working on the response have emphasized that the convergence of HIV and methamphetamine use demands an integrated strategy. Treating HIV alone, without addressing the addiction that often leads to needle sharing, is unlikely to slow transmission. Likewise, tackling drug use without providing HIV testing, treatment, and prevention services would leave a critical gap.
Fiji's experience also illustrates how global drug trafficking routes can reshape local health landscapes. The same geography that makes the islands a convenient stopover for narcotics shipments has helped make meth more available to local users, with public health consequences that no one anticipated when the transit trade first emerged.
International organizations, including UNAIDS, have drawn attention to the crisis as part of a broader warning about how quickly HIV can spread when prevention efforts are overwhelmed by social and economic disruption. Fiji's epidemic, described as the world's fastest-growing, serves as a case study in how addiction and infectious disease can reinforce one another.
For activists like Lal, the response must go beyond statistics. Behind each new infection is a person who may have turned to drugs amid limited opportunities and who now confronts stigma on multiple fronts — both as someone living with HIV and, often, as someone struggling with substance dependence.
As Fiji's government mobilizes emergency measures and international partners monitor the situation, the coming months will test whether the country can simultaneously confront its meth crisis and its HIV epidemic. Experts agree that only a coordinated approach — one that treats drug use and HIV as linked challenges rather than separate ones — offers a realistic path forward.
(0)